{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:56Z","timestamp":1791560996669,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004925","name":"Texas Health and Human Services Commission","doi-asserted-by":"publisher","award":["1H79TI083288"],"award-info":[{"award-number":["1H79TI083288"]}],"id":[{"id":"10.13039\/100004925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00520-026-11273-x","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:15:54Z","timestamp":1791512154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in opioid prescribing and high-risk co-prescribing after implementation of the 2016 CDC opioid guideline among older adults with and without cancer"],"prefix":"10.1007","volume":"34","author":[{"given":"Olajumoke A.","family":"Olateju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Young","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chijioke M.","family":"Okeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6017-7500","authenticated-orcid":false,"given":"J. Douglas","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"26","key":"11273_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","volume":"66","author":"GP Guy","year":"2017","unstructured":"Guy GP, Zhang K, Bohm MK et al (2017) Vital signs: changes in opioid prescribing in the United States, 2006\u20132015. MMWR Morb Mortal Wkly Rep 66(26):697\u2013704. https:\/\/doi.org\/10.15585\/mmwr.mm6626a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"15","key":"11273_CR2","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R (2016) CDC Guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA 315(15):1624\u20131645. https:\/\/doi.org\/10.1001\/jama.2016.1464","journal-title":"JAMA"},{"issue":"16","key":"11273_CR3","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1200\/JCO.2013.52.4827","volume":"32","author":"JH Kwon","year":"2014","unstructured":"Kwon JH (2014) Overcoming barriers in cancer pain management. J Clin Oncol 32(16):1727\u20131733. https:\/\/doi.org\/10.1200\/JCO.2013.52.4827","journal-title":"J Clin Oncol"},{"issue":"27","key":"11273_CR4","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","volume":"34","author":"JA Paice","year":"2016","unstructured":"Paice JA, Portenoy R, Lacchetti C et al (2016) Management of chronic pain in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol 34(27):3325\u20133345. https:\/\/doi.org\/10.1200\/JCO.2016.68.5206","journal-title":"J Clin Oncol"},{"issue":"6","key":"11273_CR5","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.3390\/curroncol30060437","volume":"30","author":"H Harsanyi","year":"2023","unstructured":"Harsanyi H, Cuthbert C, Schulte F (2023) The stigma surrounding opioid use as a barrier to cancer-pain management: an overview of experiences with fear, shame, and poorly controlled pain in the context of advanced cancer. Curr Oncol 30(6):5835\u20135848. https:\/\/doi.org\/10.3390\/curroncol30060437","journal-title":"Curr Oncol"},{"issue":"6","key":"11273_CR6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MHJ van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA (2016) Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symp Manag 51(6):1070-1090.e9. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340","journal-title":"J Pain Symp Manag"},{"issue":"11","key":"11273_CR7","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1377\/hlthaff.2021.00135","volume":"40","author":"T Townsend","year":"2021","unstructured":"Townsend T, Cerd\u00e1 M, Bohnert A, Lagisetty P, Haffajee RL (2021) CDC Guideline for opioid prescribing associated with reduced dispensing to certain patients with chronic pain. Health Aff (Millwood) 40(11):1766\u20131775. https:\/\/doi.org\/10.1377\/hlthaff.2021.00135","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"11273_CR8","doi-asserted-by":"publisher","first-page":"e2031647","DOI":"10.1001\/jamanetworkopen.2020.31647","volume":"3","author":"K Bykov","year":"2020","unstructured":"Bykov K, Bateman BT, Franklin JM, Vine SM, Patorno E (2020) Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States. JAMA Netw Open 3(12):e2031647. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.31647","journal-title":"JAMA Netw Open"},{"issue":"9","key":"11273_CR9","first-page":"24","volume":"18","author":"ZA Marcum","year":"2010","unstructured":"Marcum ZA, Hanlon JT (2010) Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care 18(9):24\u201327","journal-title":"Ann Longterm Care"},{"key":"11273_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2698","author":"TW Park","year":"2015","unstructured":"Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert ASB (2015) Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. https:\/\/doi.org\/10.1136\/bmj.h2698","journal-title":"BMJ"},{"key":"11273_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j760","volume":"356","author":"EC Sun","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S (2017) Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 356:j760. https:\/\/doi.org\/10.1136\/bmj.j760","journal-title":"BMJ"},{"issue":"5","key":"11273_CR12","doi-asserted-by":"publisher","first-page":"e259043","DOI":"10.1001\/jamanetworkopen.2025.9043","volume":"8","author":"R Rodin","year":"2016","unstructured":"Rodin R, Li L, McKendrick K et al (2016) The 2016 CDC opioid guideline and analgesic prescribing patterns in older adults with cancer. JAMA Netw Open 8(5):e259043. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.9043","journal-title":"JAMA Netw Open"},{"issue":"5","key":"11273_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.6004\/jnccn.2021.7104","volume":"20","author":"LM Sabik","year":"2022","unstructured":"Sabik LM, Eom KY, Sun Z et al (2022) Patterns and trends in receipt of opioids among patients receiving treatment for cancer in a large health system. J Natl Compr Canc Netw 20(5):460-467.e1. https:\/\/doi.org\/10.6004\/jnccn.2021.7104","journal-title":"J Natl Compr Canc Netw"},{"issue":"19","key":"11273_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70027","volume":"131","author":"LVM Baum","year":"2025","unstructured":"Baum LVM, Soulos PR, Kc M et al (2025) Opioid prescribing trends and pain scores among adult patients with cancer in a large health system. Cancer 131(19):e70027. https:\/\/doi.org\/10.1002\/cncr.70027","journal-title":"Cancer"},{"issue":"20","key":"11273_CR15","doi-asserted-by":"publisher","first-page":"e70211","DOI":"10.1002\/cam4.70211","volume":"13","author":"Y Chen","year":"2024","unstructured":"Chen Y, Shin YE, Spillane S et al (2024) Patterns and predictors of opioid dispensing among older cancer patients from 2008 to 2015. Cancer Med 13(20):e70211. https:\/\/doi.org\/10.1002\/cam4.70211","journal-title":"Cancer Med"},{"issue":"2","key":"11273_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkae012","volume":"8","author":"SC Mudumbai","year":"2024","unstructured":"Mudumbai SC, He H, Chen JQ et al (2024) Opioid use in cancer patients compared with noncancer pain patients in a veteran population. JNCI Cancer Spectr 8(2):pkae012. https:\/\/doi.org\/10.1093\/jncics\/pkae012","journal-title":"JNCI Cancer Spectr"},{"issue":"11","key":"11273_CR17","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1200\/OP-24-00782","volume":"21","author":"S Admane","year":"2016","unstructured":"Admane S, Bramati PS, Fellman B et al (2016) Trends in outpatient opioid prescriptions for cancer pain between 2016 and 2021. JCO Oncol Pract 21(11):1656\u20131664. https:\/\/doi.org\/10.1200\/OP-24-00782","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"11273_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/add.14886","volume":"115","author":"TW Park","year":"2020","unstructured":"Park TW, Larochelle MR, Saitz R, Wang N, Bernson D, Walley AY (2020) Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Addiction 115(5):924\u2013932. https:\/\/doi.org\/10.1111\/add.14886","journal-title":"Addiction"},{"key":"11273_CR19","unstructured":"(n.d.) SEER-medicare linked data resource. https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/. Accessed 17 Aug 2023"},{"issue":"55","key":"11273_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jncimonographs\/lgz029","volume":"2020","author":"L Enewold","year":"2020","unstructured":"Enewold L, Parsons H, Zhao L et al (2020) Updated overview of the SEER-medicare data: enhanced content and applications. J Natl Cancer Inst Monogr 2020(55):3\u201313. https:\/\/doi.org\/10.1093\/jncimonographs\/lgz029","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"11273_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/MMWR.RR7103A1","volume":"71","author":"D Dowell","year":"2023","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R (2023) CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022. MMWR Recomm Rep 71(3):1\u201395. https:\/\/doi.org\/10.15585\/MMWR.RR7103A1","journal-title":"MMWR Recomm Rep"},{"key":"11273_CR22","unstructured":"National Cancer Institute (n.d.) Common cancer sites - cancer stat facts. SEER.\u00a0 https:\/\/seer.cancer.gov\/statfacts\/html\/common.html.\u00a0Accessed 22 June 2026"},{"issue":"3","key":"11273_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.22603\/ssrr.2021-0169","volume":"7","author":"S Dohzono","year":"2022","unstructured":"Dohzono S, Sasaoka R, Takamatsu K, Nakamura H (2022) Association between Opioid Requirement and Overall Survival in Patients with Spinal Metastases. Spine Surg Relat Res 7(3):235\u2013241. https:\/\/doi.org\/10.22603\/ssrr.2021-0169","journal-title":"Spine Surg Relat Res"},{"issue":"3","key":"11273_CR24","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/j.jpainsymman.2021.09.011","volume":"63","author":"M Evenepoel","year":"2022","unstructured":"Evenepoel M, Haenen V, De Baerdemaecker T et al (2022) Pain Prevalence During Cancer Treatment: A Systematic Review and Meta-Analysis. J Pain Sympt Manag 63(3):e317\u2013e335. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.09.011","journal-title":"J Pain Sympt Manag"},{"issue":"26","key":"11273_CR25","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1200\/JCO.21.00476","volume":"39","author":"AC Enzinger","year":"2021","unstructured":"Enzinger AC, Ghosh K, Keating NL, Cutler DM, Landrum MB, Wright AA (2021) US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life. J Clin Oncol 39(26):2948\u20132958. https:\/\/doi.org\/10.1200\/JCO.21.00476","journal-title":"J Clin Oncol"},{"issue":"4","key":"11273_CR26","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/cncr.32593","volume":"126","author":"AW Roberts","year":"2020","unstructured":"Roberts AW, Fergestrom N, Neuner JM, Winn AN (2020) New-Onset Persistent Opioid Use Following Breast Cancer Treatment in Older Adult Women. Cancer 126(4):814\u2013822. https:\/\/doi.org\/10.1002\/cncr.32593","journal-title":"Cancer"},{"key":"11273_CR27","unstructured":"Centers for Disease Control and Prevention (2023) Opioid National Drug Code and Oral MME Conversion File Update | Opioids | CDC.\u00a0https:\/\/archive.cdc.gov\/www_cdc_gov\/opioids\/data-resources\/index.html. Accessed 22 Dec 2025"},{"key":"11273_CR28","unstructured":"U.S. Food and Drug Administration (2024) FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. FDA.\u00a0\u00a0https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or. Accessed 22 Dec 2025"},{"issue":"4","key":"11273_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/pop.2019.0128","volume":"23","author":"S Musich","year":"2020","unstructured":"Musich S, Wang SS, Slindee LB, Ruiz J, Yeh CS (2020) Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults. Popul Health Manag 23(4):286\u2013296. https:\/\/doi.org\/10.1089\/pop.2019.0128","journal-title":"Popul Health Manag"},{"key":"11273_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/JPR.S122853","volume":"10","author":"CS Zin","year":"2017","unstructured":"Zin CS, Ismail F (2017) Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses. JPR 10:249\u2013257. https:\/\/doi.org\/10.2147\/JPR.S122853","journal-title":"JPR"},{"key":"11273_CR31","unstructured":"Centers for Medicare & Medicaid Services (2019) Reduce Risk of Opioid Overdose Deaths by Avoiding and Reducing Co-Prescribing Benzodiazepines.\u00a0\u00a0https:\/\/www.cms.gov\/Outreach-and-Education\/Medicare-Learning-Network-MLN\/MLNMattersArticles\/Downloads\/SE19011.pdf. Accessed 22 Dec 2025"},{"key":"11273_CR32","unstructured":"Blue Cross Blue Shield of Rhode Island (n.d.) New Part D Star Measures \u2013 Concurrent Use of Opioid and Benzodiazepine, and Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults. Blue Cross & Blue Shield of Rhode Island. https:\/\/www.bcbsri.com\/providers\/update\/new-part-d-star-measures-concurrent-use-opioid-and-benzodiazepine-and-polypharmacy-use. Accessed 22 Dec 2025"},{"key":"11273_CR33","unstructured":"Center for Medicare and Medicaid Services (2016) Concurrent Use of Opioids and Benzodiazepines in a Medicare Part D Population.\u00a0\u00a0https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/Concurrent-Use-of-Opioids-and-Benzodiazepines-in-a-Medicare-Part-D-Population-CY-2015.pdf. Accessed 22 Dec 2025"},{"issue":"6","key":"11273_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/ADM.0000000000000354","volume":"11","author":"FL McClure","year":"2017","unstructured":"McClure FL, Niles JK, Kaufman HW, Gudin J (2017) Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory. J Addict Med 11(6):420. https:\/\/doi.org\/10.1097\/ADM.0000000000000354","journal-title":"J Addict Med"},{"issue":"5","key":"11273_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/EDE.0000000000001755","volume":"35","author":"G Wang","year":"2024","unstructured":"Wang G, Hamad R, White JS (2024) Advances in difference-in-differences methods for policy evaluation research. Epidemiology 35(5):628\u2013637. https:\/\/doi.org\/10.1097\/EDE.0000000000001755","journal-title":"Epidemiology"},{"issue":"6","key":"11273_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","volume":"169","author":"ASB Bohnert","year":"2018","unstructured":"Bohnert ASB, Guy GP, Losby JL (2018) Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline. Ann Intern Med 169(6):367\u2013375. https:\/\/doi.org\/10.7326\/M18-1243","journal-title":"Ann Intern Med"},{"issue":"7","key":"11273_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jpain.2022.01.006","volume":"23","author":"LR Gorfinkel","year":"2014","unstructured":"Gorfinkel LR, Hasin D, Saxon AJ et al (2014) Trends in prescriptions for non-opioid pain medications among U.S. adults with moderate or severe pain, 2014-2018. J Pain 23(7):1187\u20131195. https:\/\/doi.org\/10.1016\/j.jpain.2022.01.006","journal-title":"J Pain"},{"issue":"9","key":"11273_CR38","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40266-025-01237-x","volume":"42","author":"K Bhattacharya","year":"2013","unstructured":"Bhattacharya K, Bazzazzadehgan S, Leong NWI et al (2013) Prescription opioid use in older adults: trends and changes in new and long-term use in the United States, 2013\u20132020. Drugs Aging 42(9):887\u2013898. https:\/\/doi.org\/10.1007\/s40266-025-01237-x","journal-title":"Drugs Aging"},{"issue":"8","key":"11273_CR39","doi-asserted-by":"publisher","first-page":"e0272142","DOI":"10.1371\/journal.pone.0272142","volume":"17","author":"S Bandara","year":"2022","unstructured":"Bandara S, Bicket MC, McGinty EE (2022) Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012\u20132019. PLoS One 17(8):e0272142. https:\/\/doi.org\/10.1371\/journal.pone.0272142","journal-title":"PLoS One"},{"issue":"8","key":"11273_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.13605","volume":"3","author":"V Jairam","year":"2020","unstructured":"Jairam V, Yang DX, Verma V, Yu JB, Park HS (2020) National patterns in prescription opioid use and misuse among cancer survivors in the United States. JAMA Netw Open 3(8):e2013605. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.13605","journal-title":"JAMA Netw Open"},{"issue":"3","key":"11273_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3322\/caac.21453","volume":"68","author":"BM Scarborough","year":"2018","unstructured":"Scarborough BM, Smith CB (2018) Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin 68(3):182\u2013196. https:\/\/doi.org\/10.3322\/caac.21453","journal-title":"CA Cancer J Clin"},{"key":"11273_CR42","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0038","author":"National Cancer Comprehensive Network","year":"2019","unstructured":"National Cancer Comprehensive Network (2019) Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. https:\/\/doi.org\/10.6004\/jnccn.2019.0038","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"11273_CR43","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MHJ van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437\u20131449. https:\/\/doi.org\/10.1093\/annonc\/mdm056","journal-title":"Ann Oncol"},{"issue":"6","key":"11273_CR44","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jpainsymman.2014.03.008","volume":"48","author":"A Kotlinska-Lemieszek","year":"2014","unstructured":"Kotlinska-Lemieszek A, Paulsen O, Kaasa S, Klepstad P (2014) Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients. J Pain Symptom Manage 48(6):1145\u20131159. https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.03.008","journal-title":"J Pain Symptom Manage"},{"key":"11273_CR45","unstructured":"The Healthcare Fraud Prevention Partnership (2017) Healthcare Payer Strategies to Reduce the Harms of Opioids.\u00a0\u00a0https:\/\/www.cms.gov\/files\/document\/download-reducing-harms-opioids-white-paper.pdf. Accessed 3 Mar 2026"},{"issue":"2","key":"11273_CR46","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.37765\/ajmc.2022.88829","volume":"28","author":"MS Andersen","year":"2022","unstructured":"Andersen MS, Lorenz V, Pant A, Bray JW, Alexander GC (2022) Association of Opioid Utilization Management with Prescribing and Overdose. Am J Manag Care 28(2):e63\u2013e68. https:\/\/doi.org\/10.37765\/ajmc.2022.88829","journal-title":"Am J Manag Care"},{"key":"11273_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/DHPS.S360832","volume":"14","author":"L Murphy","year":"2022","unstructured":"Murphy L, Leblanc K, Badr S et al (2022) Opioid Utilization and Management in the Setting of Stewardship During Inpatient Rehab Care. Drug Healthc Patient Saf 14:161\u2013170. https:\/\/doi.org\/10.2147\/DHPS.S360832","journal-title":"Drug Healthc Patient Saf"},{"key":"11273_CR48","unstructured":"American Society of Clinical Oncology (2019) CDC Issues Key Clarification on Guideline for Prescribing Opioids for Chronic Pain.\u00a0\u00a0https:\/\/www.asco.org\/news-initiatives\/policy-news-analysis\/cdc-issues-key-clarification-guideline-prescribing-opioids?utm_source=chatgpt.com. Accessed 27 June 2026"},{"key":"11273_CR49","doi-asserted-by":"crossref","unstructured":"Waldfogel JM, Rosen M, Sharma R, Zhang A, Bass EB, Dy SM (2023) Opioid Stewardship: Rapid Review. In: Making Healthcare Safer IV: A Continuous Updating of Patient Safety Harms and Practices. Agency for Healthcare Research and Quality (US). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK598858\/. Accessed 27 June 2026","DOI":"10.23970\/AHRQEPC_MHS4OPIOID"},{"issue":"2","key":"11273_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0919","volume":"1","author":"I Hernandez","year":"2018","unstructured":"Hernandez I, He M, Brooks MM, Zhang Y (2018) Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries. JAMA Netw Open 1(2):e180919. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0919","journal-title":"JAMA Netw Open"},{"issue":"7","key":"11273_CR51","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/ARCHINTERNMED.2011.117","volume":"171","author":"T Gomes","year":"2011","unstructured":"Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN (2011) Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 171(7):686\u2013691. https:\/\/doi.org\/10.1001\/ARCHINTERNMED.2011.117","journal-title":"Arch Intern Med"},{"issue":"3","key":"11273_CR52","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/cncr.33963","volume":"128","author":"T Salz","year":"2022","unstructured":"Salz T, Mishra A, Gennarelli RL et al (2022) Safety of opioid prescribing among older cancer survivors. Cancer 128(3):570\u2013578. https:\/\/doi.org\/10.1002\/cncr.33963","journal-title":"Cancer"},{"key":"11273_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf072","author":"DK Check","year":"2025","unstructured":"Check DK, Soneji S, Cohen HJ et al (2025) Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer. JNCI J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djaf072","journal-title":"JNCI J Natl Cancer Inst"},{"key":"11273_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1415","volume":"361","author":"A Pitman","year":"2018","unstructured":"Pitman A, Suleman S, Hyde N, Hodgkiss A (2018) Depression and anxiety in patients with cancer. BMJ 361:k1415. https:\/\/doi.org\/10.1136\/bmj.k1415","journal-title":"BMJ"},{"issue":"2","key":"11273_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpainsymman.2016.12.342","volume":"54","author":"C Miaskowski","year":"2017","unstructured":"Miaskowski C, Mastick J, Paul SM et al (2017) Chemotherapy-Induced Neuropathy in Cancer Survivors. J Pain Symptom Manage 54(2):204-218.e2. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.12.342","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"11273_CR56","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1177\/10547738221092146","volume":"31","author":"M Al Maqbali","year":"2022","unstructured":"Al Maqbali M, Al Sinani M, Alsayed A, Gleason AM (2022) Prevalence of sleep disturbance in patients with cancer: a systematic review and meta-analysis. Clin Nurs Res 31(6):1107\u20131123. https:\/\/doi.org\/10.1177\/10547738221092146","journal-title":"Clin Nurs Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11273-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:02:01Z","timestamp":1791558121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11273-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11273"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11273-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Datasets are de-identified and fully compliant with the Health Insurance Portability and Accountability Act (HIPAA); therefore the Penn State Cancer Institute Institutional Review Board deemed the study exempt from human subjects\u2019 review.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":4,"name":"Ethics","label":"Prior presentations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1076"}}